Mark Liu
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark Liu.
Enzyme and Microbial Technology | 2000
Ronald L. Hanson; Jeffrey M. Howell; Thomas L. LaPorte; Mary Jo Donovan; Dana L Cazzulino; Valerie Zannella; Michael A. Montana; Venkata B. Nanduri; Steven R. Schwarz; Ronald F Eiring; Susan C Durand; John Wasylyk; William L. Parker; Mark Liu; Francis J. Okuniewicz; Bang-Chi Chen; John C. Harris; Kenneth J. Natalie; Keith Ramig; Shankar Swaminathan; Victor W. Rosso; Shawn K. Pack; Bruce T Lotz; Peter J. Bernot; Andrew Rusowicz; David A. Lust; Kai S Tse; John J. Venit; Laszlo J. Szarka; Ramesh N. Patel
Allysine ethylene acetal [(S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid (2)] was prepared from the corresponding keto acid by reductive amination using phenylalanine dehydrogenase (PDH) from Thermoactinomyces intermedius ATCC 33205. Glutamate, alanine, and leucine dehydrogenases, and PDH from Sporosarcina species (listed in order of increasing effectiveness) also gave the desired amino acid but were less effective. The reaction requires ammonia and NADH. NAD produced during the reaction was recyled to NADH by the oxidation of formate to CO(2) using formate dehydrogenase (FDH). PDH was produced by growth of T. intermedius ATCC 33205 or by growth of recombinant Escherichia coli or Pichia pastoris expressing the Thermoactinomyces enzyme. Using heat-dried T. intermedius as a source of PDH and heat-dried Candida boidinii SC13822 as a source of FDH,98%, but production of T. intermedius could not be scaled up. Using heat-dried recombinant E. coli as a source of PDH and heat-dried Candida boidinii 98%. In a third generation process, heat-dried methanol-grown P. pastoris expressing endogenous FDH and recombinant Thermoactinomyces98% ee.
Applied Microbiology and Biotechnology | 1992
Ramesh N. Patel; Mark Liu; Amit Banerjee; Laszlo J. Szarka
SummaryA key chiral intermediate lactol(3)[3aS (3aα,4α,7α,7aα)]-hexahydro-4,7-epoxy-isobenzofuran-1 (3H)-one was prepared for the total synthesis of a new thromboxane antagonist. The stereoselective hydrolysis of (exo,exo)-7-oxabicyclo[2.2.1]heptane-2,3-dimethanol, diacetate ester (1) to the corresponding chiral monoacetate ester (2) was carried out with lipases, among which Amano P-30 lipase from Pseudomonas sp. was most effective since it gave the desired enantiomer of monoacetate ester. A yield of 75 mol% and optical purity of >99% was obtained when the reaction was conducted in a biphasic system with 10% toluene at 5 g/l of the substrate. Lipase P-30 was immobilized on Accurel polypropylene (PP) and the immobilized enzyme was reused (five cycles) without loss of enzyme activity, productivity or optical purity. The reaction process was scaled-up to 80 1 (400 g substrate) and monoacetate (2) was isolated in 80 mol% yield with 99.3% optical purity as determined by chiral HPLC and nuclear magnetic resonance (NMR) analysis. A gas chromatography of 99.5% and specific rotation, [α]D of -7.6° was obtained. The chiral monoacetate ester (2) was oxidized to its corresponding aldehyde and subsequently hydrolyzed to give lactol (3).
Enzyme and Microbial Technology | 1992
Ramesh N. Patel; Mark Liu; Amit Banerjee; John K. Thottathil; John Kloss; Laszlo J. Szarka
Abstract A key chiral intermediate, lactol 2[3aS(3aα, 4α, 7α, 7aα)]-hexahydro-4,7-epoxy-isobenzofuran-1 (3H)-one, and the corresponding chiral lactone 3 were made in high optical purity by stereoselective enzymatic and microbial oxidation of the parent diol 1 . Horse liver alcohol dehydrogenase (HLADH) in the presence of nicotinamide adenine dinucleotide (NAD + ) and riboflavin oxidized diol 1 (exo, exo)-7-oxabicyclo [2.2.1] heptane-2,3-dimethanol to the corresponding lactol 2 and lactone 3 . Regeneration of NAD + required for the oxidation of diol 1 was carried out by the NADH-dependent alanine dehydrogenase and leucine dehydrogenase in the presence of alanine and leucine, respectively. Since expensive enzyme (HLADH) and cofactors (NAD + ) were required for the oxidation reaction, various microorganisms were screened for the ability to catalyze the stereoselective oxidation of diol 1 . Two organisms, Nocardia globerula ATCC 21505 and Rhodococcus sp. ATCC 15592, catalyzed the efficient oxidation of diol 1 to the corresponding chiral lactol 2 and lactone 3 . The reaction yield of 70% and optical purity of 96% was obtained for lactone 3 prepared from the oxidation of diol 1 by cell suspensions (10% w/v, wet cells) of N. globerula ATCC 21505. Substrate was used at 5 gl −1 concentration. A 10% (w/v, wet cells) cell suspension of Rhodococcus sp. ATCC 15592, after 120 h reaction period, produced lactol 2 in 12% yield and lactone 3 in 34% yield. An overall 46% reaction yield was obtained based on diol 1 oxidation. Substrate was used at 5 gl −1 concentration. Optical purity of 96.7% and 98.4% was obtained for lactol 2 and lactone 3 , respectively. Lactone 3 purified by slilica gel chromatography gave a specific rotation of +117° and enantiomeric excess of >99%.
Biotechnology and Applied Biochemistry | 2009
Brian L Davis; Mark Liu; Ronald L. Hanson; William L. Parker; Ramesh N. Patel
A total of 39 microbes were screened for the ability to selectively N‐demethylate (3R,5S,E)‐7‐(4‐(4‐fluorophenyl)‐6‐isopropyl‐2‐(methyl(1‐methyl‐1H‐1,2,4‐triazol‐5‐yl)aminopyrimidin‐5‐yl)‐3,5‐dihydroxy‐hept‐6‐enoic acid (I), a potential drug for lowering blood cholesterol levels. Two Streptomyces species were found to carry out the desired N‐demethylation. Bioconversion by Streptomyces griseus A.T.C.C. 13273 and product recovery were scaled up to the multi‐gram level.
Tetrahedron-asymmetry | 2005
Ramesh N. Patel; Linda Chu; Venkata B. Nanduri; Jianqing Li; Atul S. Kotnis; William L. Parker; Mark Liu; Richard H. Mueller
Biotechnology and Applied Biochemistry | 1993
Ramesh N. Patel; Amit Banerjee; Mark Liu; Ronald L. Hanson; Raphael Y. Ko; Jeffrey M. Howell; Laszlo J. Szarka
Tetrahedron-asymmetry | 2005
Ronald L. Hanson; William L. Parker; David B. Brzozowski; Mark Liu; Atul S. Kotnis; Ramesh N. Patel
Organic Process Research & Development | 2003
Ambarish K. Singh; Raymond E. Weaver; Gerald L. Powers; Victor W. Rosso; Chenkou Wei; David A. Lust; Atul S. Kotnis; F. Taha Comezoglu; Mark Liu; Kenneth S. Bembenek; Bich D. Phan; Dale Vanyo; Merrill L. Davies; Rachel Mathew; Venkatapuram Palaniswamy; Wen-Sen Li; Kumar Gadamsetti; Ciro J. Spagnuolo; William J. Winter
Enzyme and Microbial Technology | 2009
Robert M. Johnston; Linda N. Chu; Mark Liu; Steven L. Goldberg; Animesh Goswami; Ramesh N. Patel
Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry | 1992
Ramesh N. Patel; Mark Liu; Amit Banerjee; Laszlo J. Szarka